Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Acta Neuropathologica
|
February 4, 2014
TMEM106B: a strong FTLD disease modifier
Yuetiva Deming, Carlos Cruchaga
Expert Opinion on Therapeutic Targets
|
June 12, 2018
Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?
Yuetiva Deming, Zeran Li, Bruno A Benitez, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 4, 2015
Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease
Sheng Chih Jin, Bruno A Benitez, Yuetiva Deming, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2023
Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
Apolipoprotein E moderates the association between Non-<i>APOE</i> Polygenic Risk Score for Alzheimer's Disease and Aging on Preclinical Cognitive Function
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2024
Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Experimental Gerontology
|
February 13, 2017
CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN
David W Fardo, Yuriko Katsumata, John S K Kauwe, et al.
Alzheimer'S Research & Therapy
|
August 30, 2018
Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
Taylor J Maxwell, Chris Corcoran, Jorge L Del-Aguila, et al.
Neurobiology of Aging
|
February 4, 2018
An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk
Shuquan Rao, Mahdi Ghani, Zhiyun Guo, et al.
Acta Neuropathologica
|
January 13, 2016
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio, Yuetiva Deming, Jorge L Del-Águila, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Acta Neuropathologica
|
February 4, 2014
TMEM106B: a strong FTLD disease modifier
Yuetiva Deming, Carlos Cruchaga
Expert Opinion on Therapeutic Targets
|
June 12, 2018
Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?
Yuetiva Deming, Zeran Li, Bruno A Benitez, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
August 4, 2015
Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease
Sheng Chih Jin, Bruno A Benitez, Yuetiva Deming, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 20, 2023
Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
Apolipoprotein E moderates the association between Non-<i>APOE</i> Polygenic Risk Score for Alzheimer's Disease and Aging on Preclinical Cognitive Function
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2024
Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals
Yuexuan Xu, Zhongxuan Sun, Erin Jonaitis, et al.
Experimental Gerontology
|
February 13, 2017
CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN
David W Fardo, Yuriko Katsumata, John S K Kauwe, et al.
Alzheimer'S Research & Therapy
|
August 30, 2018
Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
Taylor J Maxwell, Chris Corcoran, Jorge L Del-Aguila, et al.
Neurobiology of Aging
|
February 4, 2018
An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk
Shuquan Rao, Mahdi Ghani, Zhiyun Guo, et al.
Acta Neuropathologica
|
January 13, 2016
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio, Yuetiva Deming, Jorge L Del-Águila, et al.
Page
of 6